Research Institute for Future Food (RiFood) at The Hong Kong Polytechnic University (PolyU) is pleased to announce the launch of a clinical study on the allergenicity of partially hydrolysed infant formulas (pHFs) available in the Hong Kong market.
pHFs are designed as milk substitutes for infants and toddlers diagnosed with cow’s milk protein allergy (CMPA). By breaking down milk proteins into smaller fragments and peptides, these formulas aim to reduce allergenic potential. Previous research by Dr. Kong Hang-kin, Senior Research Fellow at RiFood, revealed significant differences in allergenicity among pHFs currently available. This new cohort study will clinically evaluate these formulas and assess the risk of allergic reactions in infants and toddlers with CMPA or atopic dermatitis (eczema).
The findings will provide valuable guidance for pediatricians, dietitians, and healthcare professionals in recommending suitable formulas for young children.
Study Details
- Approved by the PolyU Institutional Review Board (Ref: HSEARS20251008010-01)
- Recruiting:
✔ Healthy infants and toddlers (aged 6 months to 4 years)
✔ Healthy children, but with family history of eczema or CMPA
✔ Children diagnosed with eczema or CMPA
- Purpose: To assess allergenic risks and improve dietary recommendations for children with allergies
Contact & Enrolment
- Phone: 3400 8708
- Online form: Enrolment / Inquiry Form (https://forms.gle/joBD7ViDv1qibTv38).
Your participation will contribute to advancing clinical knowledge and improving nutrition guidance for children with allergies.
